ProstateCancerNews
www.medpagetoday.com -
3/14/13
(MedPage Today) -- WASHINGTON, D.C. -- Medicare will pay for so-called FDG-PET scans for monitoring malignant tumors in routine practice, except in prostate cancer, according to a proposed decision memo.
www.medpagetoday.com -
2/17/13
ORLANDO (MedPage Today) -- More than 90% of men with high-risk castration-resistant prostate cancer had significant biochemical responses to a novel anti-androgen, results of small clinical trial showed.
www.medpagetoday.com -
2/15/13
ORLANDO (MedPage Today) -- Survival improved and disease progression slowed in men with metastatic castration-resistant prostate cancer treated in first line with abiraterone acetate (Zytiga).
www.medpagetoday.com -
2/14/13
ORLANDO (MedPage Today) -- Immediate radiation therapy after radical prostatectomy led to a 50% increase in long-term biochemical progression-free survival for patients with locally advanced prostate cancer, according to a study reported here.
www.medpagetoday.com -
2/14/13
ORLANDO (MedPage Today) -- Men with castration-resistant prostate cancer had worse survival when treated with corticosteroids, regardless of their primary treatment, a post-hoc analysis of a randomized trial showed.
Result Pages: 1 2 3 4 5 6 7 8 9 10 Next |
|
||
